Work

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.536

Authors: Thomas W. Flaig, Catherine Tangen, Siamak Daneshmand, Ajjai Shivaram Alva, M. Scott Lucia, David McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I. Milowsky, Rick Bangs, Gary R. MacVicar, Bruno R. Bastos, Jared Fowles, Daniel Gustafson, Melissa Plets, Ian Murchie Thompson, Seth P. Lerner

Institutions: University of Colorado Anschutz, Fred Hutch Cancer Center, USC Norris Comprehensive Cancer Center, U-M Rogel Cancer Center, Johns Hopkins University, Cedars-Sinai Medical Center, University of Southern California, University of North Carolina at Chapel Hill, Bladder Cancer Advocacy Network, Illinois CancerCare, Cleveland Clinic, Cleveland Clinic Florida, Huntsman Cancer Institute, Colorado State University, Christus Santa Rosa Health System, Baylor College of Medicine

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4213097742

Cites:

Cited by: 5

Related to: 10